Skip to content

The impact of pre-habilitation on post-operative complications in patients undergoing Whipple surgery

Impact of Implementation of prehabilitation augmented enhanced recovery after surgery(PERAS) protocol in elective pancreatico-duodenectomy surgery: An open-labelled randomized control trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111551
Enrollment
60
Registered
2026-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C250- Malignant neoplasm of head of pancreas

Interventions

Intervention1: Prehabilitation augmented ERAS protocol: 1. Nutritional: High protein diet and specific diet chart to meet the required kcals 2. Psychological: One to one counseling along with relaxat

Sponsors

Dr Satish S N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Resectable periampullary carcinoma, carcinoma head of pancreas, duodenal adenocarcinoma within 2 cm of ampulla and distal cholangiocarcinoma requiring Pancreatico-duodenectomy 2. Able to provide informed consent 3. ASA I / II patients

Exclusion criteria

Exclusion criteria: 1. Inability to comprehend or follow the PERAS protocol 2. Patients not providing valid informed consent 3. Pregnant patients 4. Patients with psychiatric disorders 5. Unresectable disease 6. ASA more than III

Design outcomes

Primary

MeasureTime frame
To compare the length of stay in hospital, postoperative complications, and readmission rates between patients managed with Prehabilitation augmented ERAS and those receiving traditional ERAS care.Timepoint: At baseline, after 4 weeks and after 8 weeks

Secondary

MeasureTime frame
1.To assess patient-reported outcomes, such as pain scores, bowel function recovery, quality of life and emotional well-being in the two groups. 2.To evaluate the cost-effectiveness of the Prehabilitation augmented ERAS protocol in comparison to traditional ERAS pathways.Timepoint: At baseline, at 4 weeks & at 8 weeks

Countries

India

Contacts

Public ContactDr Satish S N

PGIMER Chandigarh

drsnsatish06@gmail.com9790674694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026